Penguin Ai raises $30M for its agentic AI

Penguin Ai raised $29.7 million for its AI platform aimed at automating costly administrative tasks like prior authorization and medical coding. CEO Fawad Butt said the startup's goal is to move beyond point solutions and create an "Epic of the healthcare back office."

Editor's Pick

Top Story Penguin Ai Snags $30M to Simplify Prior Auth, Coding and Claims Penguin Ai raised $29.7 million for its AI platform aimed at automating costly administrative tasks like prior authorization and medical coding. CEO Fawad Butt said the startup's goal is to move beyond point solutions and create an "Epic of the healthcare back office." Sponsored Navigating the Future of Benefits: Is Your Plan Keeping Up? Presented by Quantum Health and MedCity News A new report reveals that most consultants are now steering employers toward independent healthcare navigation solutions for a better member experience and clearer cost savings. The report also highlights the growing trend of GLP-1 drug coverage and the specific measures employers are using to ensure results. Ready to see how these trends will shape your strategy? Sign up now for the full report. It's Almost Here: The Best Networking - INVEST Digital Health Starts Thursday! Time is almost up to secure your spot at INVEST Digital Health. Join industry leaders for a day of powerful insights, connections, and strategies you can put into action right away. Don't miss your chance to be part of the conversations shaping the future of healthcare. Register Now

Featured News

Goodpath Rakes In $18M for Chronic Condition Platform Goodpath's Series A round was led by MassMutual Ventures and included participation from Healthy Ventures. In total, the company has raised $22 million. Long Regulatory Saga for Intercept Pharma Liver Drug Ends a Decade After Speedy FDA Approval Intercept Pharmaceuticals is voluntarily withdrawing from the market Ocaliva, a drug for the rare liver disease primary biliary cholangitis. While Ocaliva became an important new treatment option when it won accelerated FDA approval in 2016, PBC patients now have new FDA-approved medicines from Ipsen and Gilead Sciences that don't pose the same safety risks. Health Plan Leaders Reveal Underreported Medicaid Challenges, Anticipated Risks, and Solutions The coming changes in Medicaid will place health plans squarely between a rock and a hard place. Here's how plans are bracing for change. Why Traditional EMRs Are Holding Healthcare Back Instead of creating new opportunities, traditional EMRs are constraining AI's potential in healthcare.

Video   OpenAI Announces Key Healthcare Hires OpenAI hired two key new leaders for its healthcare division. The first is Nate Gross, who is the company's head of health strategy. He is the co-founder of both Rock Health and Doximity. The other new hire is Ashley Alexander, who has joined OpenAI as vice president of health products. She comes to the company from Instagram, where she most recently served as co-head of product.

Sponsored The Top-Rated Suppliers of Lu-177 for Cancer Research Presented by SHINE Technologies With carrier-added and noncarrier-added versions available, the right supplier can make the difference between a program that stalls and one that successfully reaches patients. Learn More.

Resources

MedCity Pivot Podcast: Clinical Documentation Improvement With Smarter Technologies Smarter Technologies CEO Jeremy Delinsky explains how the company's AI infrastructure can help support health system's clinical documentation improvement efforts, ultimately strengthening RCM. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe